We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The British government has entered into a contract to conduct human challenge trials in which participants will be deliberately infected with COVID-19 to bolster development of a vaccine. Read More
China’s state-owned pharmaceutical company Sinopharm is gearing up to manufacture 1 billion doses of its two potential coronavirus vaccines in 2021. Read More
Moderna CEO Stéphane Bancel said that the drugmaker’s COVID-19 vaccine candidate could receive an Emergency Use Authorization (EUA) in December if all goes according to plan, with interim data expected out next month. Read More
Self collection of samples by patients reduces the risk of virus transmission as the test does not require an in-person visit with a clinician. Read More
Fujifilm has filed for approval of its influenza drug Avigan (favipiravir) in Japan for treatment of COVID-19 patients, after the antiviral showed promise in a phase 3 trial. Read More
The Government Accountability Office (GAO) on Monday agreed to begin looking into allegations that the Trump administration exerted political pressure on the FDA and Centers for Disease Control and Prevention (CDC) to influence pandemic-related policies, following a request by three Democrat senators. Read More